Striking a Balance with Ascending Dose Studies

Time: 11:20 am
day: Clinical Stream 3


  • Understanding the unique challenges behind achieving the correct dose for FIH studies
  • How many doses should drug sponsors be including in ascending dose studies?
  • Taking into consideration immunogencitiy risks when setting upper dose limits